WHO ICTRP trial
Prophylactic application of PEG-rhG-CSF during chemoradiotherapy for cervical…
ChiCTR1900026309 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900026309 |
|---|---|
| Public title | Prophylactic application of PEG-rhG-CSF during chemoradiotherapy for cervical cancer |
| Scientific title | Prophylactic application of PEG-rhG-CSF during chemoradiotherapy for cervical cancer |
| Primary sponsor | Affiliated Cancer Hospital of Zhengzhou University, Cancer Hospital of Henan Province |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Cervical cancer |
| Interventions | Group A :PEG-rhG-CSF;Group B:PEG-rhG-CSF plus rhG-CSF;Control Group:rhG-CSF |
| Registration date | Sep 29, 2019 |
| Target size | Group A :60;Group B:60;Control Group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: